 |
| Late-Breaking Clinical Trials I was one of the most important sessions at this year's conference. Check out the enhanced, on demand version of the original presentation from this year's ACC '04 in New Orleans, LA. This CME activity consists of important late-breaking clinical trials, including PROVE IT - TIMI 22, PAVE, ALLIANCE, SCD-HeFT and DINAMIT. |
|
View Program Now!
|
Learning Objectives:
At the end of this program, it is intended for the participant to:
- Review key data from late breaking clinical trials including PROVE IT - TIMI22, ALLIANCE, SCD-HeFT, and DINAMIT
- Compare and contrast the efficacy and safety profiles of statin agents for thrombolysis in myocardial infarction patients
- Evaluate the efficacy of lipid lowering therapy as primary prevention of cardiovascular events in diabetic patients
- Examine current management strategies for patients with heart failure, including the use of implantable defibrillators and antiarrhythmic agents
- Discuss clinical outcomes for coronary heart disease patients treated with aggressive lipid lowering with statins versus those undergoing usual care strategies
Target Audience:
This program is intended for cardiologists, cardiology fellows and residents, and anyone who treats patients with cardiovascular disease.
|
|
| Christopher P. Cannon, Eugene Braunwald, for the PROVE IT - TIMI 22 Investigators |
| |
PROVE IT - TIMI 22: Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction 22 -- Statin Comparison |
| Rahul Doshi, Emile Daoud, Christopher Fellows, Kyong Turk, Aurelio Duran, Mohamed Hamdan |
| |
PAVE: The First Prospective, Randomized Study Evaluating BV Pacing After Ablate and Pace Therapy |
| Donald Hunninghake, Michael Koren, on behalf of the ALLIANCE investigators. |
| |
ALLIANCE: Comparison of Clinical Outcomes in Managed Care Patients With Coronary Heart Disease Treated in Aggressive Lipid Lowering Programs Using Atorvastatin Versus Usual Care |
| Gust H. Bardy, Kerry L. Lee, Daniel B. Mark, Jeanne E. Poole, Douglas L. Packer, Robin Boineau, Charles L. Troutman, Jill Anderson, George W. Johnson, Steven E. McNulty, Linda Davidson-Ray, Nancy Clapp-Channing, Richard M. Luceri, John H. Ip, and The SCD-HeFT Investigators |
| |
SCD-HeFT: Sudden Cardiac Death-Heart Failure Trial |
| Stuart J. Connolly, Stefan H. Hohnloser, on behalf of the DINAMIT Steering Committee and Investigators |
| |
DINAMIT: Randomized Trial of Prophylactic Implantable Defibrillator Therapy Versus Optimal Medical Treatment Early After Myocardial Infarction: The Defibrillator in Acute Myocardial Infarction Trial
|
|
|
You'll need the following plug-in(s) installed to participate in this program:
 RealPlayer® from RealNetworks® |
Download now |
|
Brief instructions to download the free player:
|
- Click on the "Our Free Player" link in the middle of the page.
- Click on the "Download the Free RealOne Player Only" link on the right-hand panel.
- Follow the on screen instructions to download the plug-in.
|
| MACINTOSH USERS using Netscape version 7 or higher, please note: |
|
Mac OS X requires RealOne Player
Follow the instructions for the OS X download. |
Download now |
Mac OS 8/OS 9 requires RealPlayer 8 for Mac:
Follow the instructions for the OS 8/OS 9 download. |
Download now |
| OR |
|
 Microsoft® Windows MediaTM Player |
Download now |
|
Brief instructions to download this player:
|
- Make sure that version that was automatically selected to download is correct.
- If so, click "Download Now!" and follow the on-screen instructions to install.
- If it is not the correct version, click "See all Windows Media Player downloads."
- Follow the on-screen instructions to select a different version and install.
|
|
|
| Accreditation Statements |
Physicians: The Cardiology Center Switzerland is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The ACCF takes responsibility for the content, quality, and scientific integrity of this CME activity. The ACCF designates this program as approved for 1.25 hours in category 1 credit toward the AMA Physician’s Recognition Award. Each physician should claim only those hours of credit that are spent in the educational activity.
The American Medical Association has determined that physicians not licensed in the US who participate in the CME activity are eligible for AMA PRA category 1 credit.
While offering CME credit hours noted above, the program is not intended to provide extensive training or certification in the field. |
| Nurses: PharmCon has been approved as a provider of Continuing Education for Nurses by the Maryland Nurses Association that is accredited as an approver of continuing education in nursing by the American Nurses Credential Center's Commission on Accreditation. The number assigned to this program is N030804-127-H01 for 1.25 credit hours. In order to receive credit for this program, each participant must view the entire program and complete an evaluation form. |
| Nurse Practitioners: This program (0403106) has been approved for 1.25 contact hours of continuing education by the American Academy of Nurse Practitioners. |
|
Physician's Assistants: AAPA accepts AMA category 1 CME credit for the PRA from organizations accredited by the ACCME. This program has been approved for 1.25 hours of continuing education credit.
View your CME Progress
|
|
|
|
|
